BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 701016)

  • 1. Removal of plutonium from beagles using Ca-DTPA and Zn-DTPA: effects on initial DTPA injection.
    Taylor GN; Lloyd RD; Boseman JJ; Atherton DR; Mays CW
    Health Phys; 1978 Aug; 35(2):201-10. PubMed ID: 701016
    [No Abstract]   [Full Text] [Related]  

  • 2. Decorporation from beagles of a mixture of monomeric and particulate plutonium using Ca-DTPA and Zn-DTPA: dependence upon frequency of administration.
    Lloyd RD; Boseman JJ; Taylor GN; Bruenger FW; Atherton DR; Stevens W; Mays CW
    Health Phys; 1978 Aug; 35(2):217-27. PubMed ID: 701018
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of Zn-DTPA and Ca-DTPA in removing plutonium from the human body.
    Ohlenschläger L; Schieferdecker H; Schmidt-Martin W
    Health Phys; 1978 Nov; 35(5):694-9. PubMed ID: 744734
    [No Abstract]   [Full Text] [Related]  

  • 4. Removal of internally deposited transuranium elements by Zn-DTPA.
    Seidel A; Volf V
    Health Phys; 1972 Jun; 22(6):779-83. PubMed ID: 5084010
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison of Ca-DTPA and Zn-DTPA for chelating 241Am in beagles.
    Lloyd RD; Mays CW; McFarland SS; Taylor GN; Atherton DR
    Health Phys; 1976 Sep; 31(3):281-4. PubMed ID: 977350
    [No Abstract]   [Full Text] [Related]  

  • 6. Simplified structure of a new model to describe urinary excretion of plutonium after systemic, liver or pulmonary contamination of rats associated with Ca-DTPA treatments.
    Fritsch P; Sérandour AL; Grémy O; Phan G; Tsapis N; Abram MC; Renault D; Fattal E; Benech H; Deverre JR; Poncy JL
    Radiat Res; 2009 Jun; 171(6):674-86. PubMed ID: 19580474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward an optimal DTPA therapy for decorporation of actinides: time-dose relationships for plutonium in the dog. I.
    Guilmette RA; Moretti ES; Lindenbaum A
    Radiat Res; 1979 Jun; 78(3):415-28. PubMed ID: 221958
    [No Abstract]   [Full Text] [Related]  

  • 8. Removal of inhaled 239PuF4 in beagles. BNWL-714.
    Dilley JV; McDonald KE
    BNWL Rep; 1968 May; ():6.11. PubMed ID: 5306301
    [No Abstract]   [Full Text] [Related]  

  • 9. Dependency of chelation efficacy upon time after first DTPA injection.
    Lloyd RD; Taylor GN; Mays CW; Jones CW; Bruenger FW; Atherton DR
    Radiat Res; 1979 Jun; 78(3):448-54. PubMed ID: 451166
    [No Abstract]   [Full Text] [Related]  

  • 10. [Late sequelae of the inhalational uptake of 239Pu under the influence of Ca- or ZnDTPA therapy].
    Levdik TI; Liubchanskii ER; Nifatov AP
    Med Radiol (Mosk); 1979 Nov; 24(11):66-71. PubMed ID: 502784
    [No Abstract]   [Full Text] [Related]  

  • 11. In vivo and in vitro chelation of plutonium by alpha-lipoic acid and DTPA. BNWL-714.
    Dilley JV
    BNWL Rep; 1968 May; ():6.12-6+. PubMed ID: 4898101
    [No Abstract]   [Full Text] [Related]  

  • 12. Calcium and zinc DTPA administration for internal contamination with plutonium-238 and americium-241.
    Kazzi ZN; Heyl A; Ruprecht J
    Curr Pharm Biotechnol; 2012 Aug; 13(10):1957-63. PubMed ID: 22352730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further comparison of Ca-DTPA and Zn-DTPA for removal of 241Am from beagles.
    Lloyd RD; Taylor GN; Boseman JJ; Mays CW; Atherton DR
    Health Phys; 1977 Jul; 33(1):92-4. PubMed ID: 893109
    [No Abstract]   [Full Text] [Related]  

  • 14. [Report on a plutonium-239 contaminated lacerated and incised wound].
    Ohlenschläger L; Schieferdecker H
    Strahlentherapie; 1973 Dec; 146(6):675-84. PubMed ID: 4792264
    [No Abstract]   [Full Text] [Related]  

  • 15. Pu and Am decorporation in beagles: effects of magnitude of initial Ca-DTPA injection upon chelation efficacy.
    Lloyd RD; Jones CW; Taylor GN; Mays CW; Atherton DR
    Radiat Res; 1979 Sep; 79(3):630-34. PubMed ID: 113846
    [No Abstract]   [Full Text] [Related]  

  • 16. Decorporation of inhaled plutonium nitrate from hamsters using Zn-DTPA.
    Stradling GN; Stather JW; Sumner SA; Strong JC; Lennox AM; Ham SE
    Health Phys; 1984 Apr; 46(4):919-24. PubMed ID: 6706599
    [No Abstract]   [Full Text] [Related]  

  • 17. A measure of the effectiveness of DTPA chelation therapy in cases of plutonium inhalation and plutonium wounds.
    Schofield GB; Lynn JC
    Health Phys; 1973 Mar; 24(3):317-26. PubMed ID: 4691640
    [No Abstract]   [Full Text] [Related]  

  • 18. Effectiveness of DTPA therapy when administered intragastrically or intraperitoneally to remove Pu from adult or neonatal rats.
    Sullivan MF; Ruemmler PS
    Health Phys; 1986 Nov; 51(5):641-6. PubMed ID: 3771225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of continuously infused DTPA therapy in reducing the radiation dose from inhaled 244Cm2O3 aerosols.
    Guilmette RA; Muggenburg BA
    Health Phys; 1992 Apr; 62(4):311-8. PubMed ID: 1597380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decorporation Approach after Rat Lung Contamination with Plutonium: Evaluation of the Key Parameters Influencing the Efficacy of a Protracted Chelation Treatment.
    Grémy O; Coudert S; Renault D; Miccoli L
    Radiat Res; 2017 Nov; 188(5):552-561. PubMed ID: 28945525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.